Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianyu Pharm supplies advanced pharmaceutical intermediates and APIs globally. It has passed US FDA and EU GMP inspections for several products. The company’s portfolio includes commercialized APIs for chronic diseases such as hypertension and diabetes. Over twenty new products are in various stages of development or registration. In August 2022 the company received an FDA warning letter regarding CGMP deviations related to impurity control in API manufacturing[8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Tianhuang Pharmaceutical.